Clear Street’s Moderna MRNA Stock Holding History

Clear Street's MRNA Position: Q2 2026 in Review

Clear Street increased its Moderna (MRNA) stake by 54% in Q2 2026, buying an estimated $308K and bringing the position to 16,968 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #405.

Clear Street first reported a position in MRNA in Q4 2022 and has held it in 4 quarters since. The position peaked at $18M in Q4 2022. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

• Clear Street held 16,968 shares of Moderna worth $1.19M as of Q2 2026.
• Clear Street bought 5,960 Moderna shares in Q2 2026, an estimated $308K.
• Moderna made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #405 holding.
• Clear Street first reported a position in Moderna in Q4 2022 and has held it in 4 quarters since.
• Clear Street's Moderna position peaked at $18M in Q4 2022.
• 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.